Medical professionals and researchers from around the world convened in Istanbul for the 2026 European Academy of Allergy and Clinical Immunology (EAACI) Congress. The summit operated under the central theme "Vision Zero: A Future Free from Allergy and Asthma Burden," facilitating global discussions on advancements in clinical immunology.
Sources:
Relief International (RI) has expanded its operational scope in Türkiye and recently published a comprehensive health needs assessment report. The report evaluates the ongoing humanitarian and medical requirements across several key regions, specifically focusing on Istanbul, Gaziantep (where the organization's headquarters are located), and Hatay. The assessment is designed to guide future health interventions and aid distribution in these specific provinces.
Source Link: ReliefWeb
Researchers affiliated with Istanbul Kent University have contributed to contemporary virological studies through the synthesis and biological evaluation of modified peptide derivatives. Published by the American Chemical Society, the peer-reviewed research outlines new chemical compounds specifically designed to target the SARS virus. This collaborative academic effort represents a notable development in biochemical research and infectious disease management originating from Istanbul-based scientific institutions.
Source: * ACS Publications: https://pubs.acs.org/
A newly published medical study has provided a comparative analysis of the efficacy and safety of two induction therapies: Leflunomide and Cyclophosphamide.
The clinical research was conducted by medical professionals affiliated with the Demiroglu Science University, Faculty of Medicine, and the Department of Internal Medicine (Division of Rheumatology) at the Istanbul Florence Nightingale Hospital. The findings, featured by the European Society of Medicine, offer valuable clinical data for the ongoing management and treatment protocols of severe rheumatological conditions.
Source:
European Society of Medicine
